Water and electrolyte imbalance in patients with metabolic syndrome
https://doi.org/10.20538/1682-0363-2012-2-40-43
Abstract
Considering the high incidence of renal impairment in metabolic syndrome (MS), an analysis of electrolyte metabolism was performed in 112 patients preoperatively and 53 patients postoperatively. Aldosterone level, adrenocorticotropic hormone level, neutrophil gelatinase-associated lipocalin level, cortisol level, β2-microglobulin level, serum vasopressin level, urinary microalbumin level measurements were taken as a combined patient assessment procedure. MS patients were found to demonstrate a decrease in circadian amounts of urea, potassium, sodium and chlorides excretion. An increase in vasopressin production and an enhancement of microalbumin excretion were detected. The specified disturbances developed as «a vicious circle»: fluid retention resulted in heperfiltration, with renal dysfunction leading to a deteriorated hydro-electrolyte imbalance. An improvement of circadian electrolyte excretion rates, as well as a decline in vasopressin and cortisol levels, occurred due to a reduction of abdominal fat volume.
About the Authors
V. N. PavlovRussian Federation
A. V. Alekseyev
Russian Federation
R. R. Ishemgulov
Russian Federation
A. A. Ismailov
Russian Federation
Zh. A. Galeyeva
Russian Federation
References
1. Байpамгулов Ф.М., Булгакова А.Д., Куpеленкова М.Е. и др. Тканевая инсулиноpезистентность и функциональное состояние эндотелия кpупных сосудов у больных аpтеpиальной гипеpтонией // Терапевт. арх. 2002. № 12. С. 24—26.
2. Казека Г.Р. Метаболический синдром. Новосибирск, 2000.
3. Мадянов И.В., Балаболкин М.И., Григорьев А.А. и др. Гиперурикемия как составляющая метаболического синдрома X // Проблемы эндокринологии. 1997. № 6. С. 30—32.
4. Фадеев В.В., Бутрова С.А., Берковская М.А. Система гемостаза и фибринолиза при метаболическом синдроме // Гематология и трансфузиология. 2009. № 5. С. 41—47.
5. Чиркин А.А., Голубев С.А. Метаболический синдром: диагностика, лечение // Мед. новости. 2002. № 10. С. 23—29.
6. Caro J.F. Clinical review 26: insulin resistance in obese and nonobese man // J. Clin Endocrinol Metab. 1991. № 73 (4). Р. 691—695.
7. De Franzo R.A., Ferranini E. Insulin resistance: a multifac-eted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic disease // Diabetes Care. 1991. № 14. Р. 173—194.
8. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the meta-bolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey // JAMA. 2002. V. 287. Р. 356—359.
9. Johannsson G., Gibney J., Wolthers T. et al. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men // J. Clin. Endocrinol. Metab. 2005. Jul. № 90 (7). Р. 3989—3994.
10. Roberge C., Carpentier A.C., Langlois M.F. et al. Adreno-cortical dysregulation as a major player in insulin resistance and onset of obesity // Am. J. Physiol. Endocrinol. Metab. 2007. Dec. № 293 (6). Р. 1465—1478.
11. Sarzani R., Salvi F., Dessì-Fulgheri P. et al. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans // J. Hypertens. 2008. May. № 26 (5). Р. 831—843.
Review
For citations:
Pavlov V.N., Alekseyev A.V., Ishemgulov R.R., Ismailov A.A., Galeyeva Zh.A. Water and electrolyte imbalance in patients with metabolic syndrome. Bulletin of Siberian Medicine. 2012;11(2):40-43. (In Russ.) https://doi.org/10.20538/1682-0363-2012-2-40-43